Thrombin Decrease in Thrombin Generation after Heparin Administration in a Homozygous Type II Heparin-Binding Site Antithrombin-Deficient Pregnant Woman

OBJECTIVES: There is a major problem in providing prophylactic treatment in antithrombin (AT)-deficient pregnant women with a homozygous mutation of the heparin-binding site and AT level of 17%. The aim of the study was to determine the effectiveness of heparin by monitoring changes in thrombin gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Malíková, Ivana, Husáková, Martina, Bílková, Jana, Brzežková, Radka, Kvasnička, Tomáš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659590/
https://www.ncbi.nlm.nih.gov/pubmed/37703851
http://dx.doi.org/10.1159/000533801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659590/
https://www.ncbi.nlm.nih.gov/pubmed/37703851
http://dx.doi.org/10.1159/000533801

Ejemplares similares